TGM2 and celiac disease: The current diagnostic pathway for coeliac disease is a two‐step process: initial testing for coeliac‐specific serological antibodies, such as anti‐tissue transglutaminase (tTG) and endomysial antibodies (EMA), followed by endoscopy and confirmatory biopsy in serology‐positive cases.5